Skip to content

GS Consult

Active Private limited companyfounded 2023active for 2 yearsKiewitstraat 28, 3550 Heusden-ZolderKBO/BCE: BE 1003.656.030

Lifetime

2 annual accounts with figures on one time axis
peak of €381,227 in 2024
€327,767▼ 14.0%
peak of €280,419 in 2024
€249,428▼ 11.1%
peak of €530,848 in 2025
€530,848▲ 88.6%
€194,436▲ 46.7%
Board1 name since 2023
1 director
Documentsfilings and deeds
24-06-202637 days before the deadline
2025micro format
Gross margin from €381,227 to €327,767Equity from €281,419 to €530,848Debts from €132,495 to €194,436Cash from €70,271 to €106,089

Key points

from the 2025 annual accounts

Equity

€530,848 ▲ 88.6%
€281,0002024€531,0002025

Equity rose in 2025 from €281,419 to €530,848.

Debts

€194,436 ▲ 46.7%
Taxes and wages
+68,280
Suppliers
+3,567
The rest
-9,906

Debts rose by €61,940 in 2025.

Position in the sector

€249,428

Higher net result than 92% of companies in human health. The sector median is €59,541, over 21,360 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,138 companies had the same profile as GS Consult has now. Each dot stands for 8 companies, two years later.

97.0%
were still trading
2.1%
stopped another way
0.8%
went bankrupt
  • Small
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,138 companies, not a prediction for GS Consult. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 22-12-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1003656030
Incorporation Founding capital of €1,000, 100 shares · Founded by · appointed as statutory director · published on 22-12-2023 · Gazette deed
First establishment Kiewitstraat 28, Heusden-Zolder
All 6 events

Comparable companies

same main activity, similar in size and age
Company
GS Consult Heusden-Zolder €725,283 €327,767 73.2% -
RX Antwerpen Zuid Antwerp €753,167 €302,487 -3.8% -
DOKTER STEFF DE SMET, PATHOLOGIE Oostkamp €679,594 €303,554 87.2% -
JULIEN JOSKIN Chaudfontaine €823,762 €331,889 73.5% -
Dr. Laurens De Vos - Cardiologie Nazareth-De Pinte €784,796 €363,494 45.6% -
MEDICALIA Thuin €689,223 €286,652 42.7% -
WALLONIE DENTAL Dour €720,139 €375,886 45.1% -

These companies have the same main activity as GS Consult: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €680,000 and €824,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 20-12-2023Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.353.602.6543550 Heusden-Zolder, since 20-12-2023
Financial year end
31 December
Peppol
Reachable since 19-12-2024
Company details

Annual accounts 2025

≈ €490,000estimated
€725,283▲ 75.2%
Filing
Filed on 24-06-2026, 37 days before the end of the filing period
Financials

Insights on GS Consult

GS Consult has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €530,848 and a net result of €249,428.

Its solvency ranks better than 61% of 21,373 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about GS Consult

What is the company number of GS Consult?
The company number of GS Consult is 1003.656.030. The VAT number is the same number with BE in front: BE 1003.656.030.
Where is GS Consult based?
The registered office is at Kiewitstraat 28, 3550 Heusden-Zolder.Company details
What does GS Consult do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of GS Consult?
GS Consult is a private limited company (BV).
When was GS Consult founded?
GS Consult was founded on 20-12-2023.
Is GS Consult still active?
Yes, GS Consult is an active enterprise in the KBO register.
What is the turnover of GS Consult?
The turnover in financial year 2025 is about €490,000. This figure is estimated from the gross margin of €327,767 and 31 comparable companies (NACE 86220). It probably lies between €440,000 and €690,000.Financials
Is GS Consult profitable?
In financial year 2025, GS Consult made a profit of €249,428.
Where can I find the annual accounts of GS Consult?
GS Consult filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GS Consult due?
GS Consult must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.